fenofibrate has been researched along with bifendate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dong, H; Feng, XD; Geng, W; Han, YF; Ko, KM; Li, N; Pan, SY; Yang, R | 1 |
Dong, H; Ko, KM; Pan, SY; Yang, R; Yu, ZL | 1 |
2 other study(ies) available for fenofibrate and bifendate
Article | Year |
---|---|
High doses of bifendate elevate serum and hepatic triglyceride levels in rabbits and mice: animal models of acute hypertriglyceridemia.
Topics: Animals; Apolipoprotein A-I; Apolipoproteins B; Biphenyl Compounds; Cholesterol; Disease Models, Animal; Dose-Response Relationship, Drug; Fenofibrate; Hypertriglyceridemia; Hypolipidemic Agents; Liver; Male; Mice; Mice, Inbred ICR; Rabbits; Triglycerides | 2006 |
Bifendate treatment attenuates hepatic steatosis in cholesterol/bile salt- and high-fat diet-induced hypercholesterolemia in mice.
Topics: Animals; Bile Acids and Salts; Biphenyl Compounds; Cholesterol; Cholesterol, Dietary; Disease Models, Animal; Dose-Response Relationship, Drug; Fatty Liver; Fenofibrate; Hypercholesterolemia; Hypolipidemic Agents; Male; Mice; Mice, Inbred ICR; Time Factors; Triglycerides | 2006 |